| Financial Year |
March 31 2023 |
| Monetary Funds |
99,430,443.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,368,804.99 |
| Accounts Receivable |
653,761,996.39 |
| Advances to Suppliers |
24,995,329.10 |
| Other Receivables |
13,562,405.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,635,207.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
242,802.97 |
| Total Current Assets |
1,356,900,593.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
225,480,899.97 |
| Under-construction Projects |
4,161,981.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,027,841.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,480,167.23 |
| Deferred Income Tax Assets |
28,240,180.73 |
| Other Non-Current Assets |
390,787.20 |
| Sub-Total of Non-Current Assets |
321,273,979.74 |
| Total Assets |
1,678,174,573.69 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,320,129.07 |
| Accounts Payable |
213,112,755.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,944,178.14 |
| Taxes Payable |
6,003,570.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,355,471.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
567,672.86 |
| Other Current Liabilities |
28,435,285.67 |
| Sub-Total of Current Liabilities |
467,073,038.39 |
| Long-term Loans |
-- |
| Bonds Payable |
124,542,019.97 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,502,239.33 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
131,639,164.27 |
| Total Liabilities |
598,712,202.66 |
| Paid-In Capital(Or Share Stock) |
200,382,361.00 |
| Capital Surplus |
378,879,888.09 |
| Surplus Reserve |
53,154,783.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
421,465,773.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,079,462,371.03 |
| Owner's Equity（Stockholder's Equity） |
1,079,462,371.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,678,174,573.69 |
